Namely, SOX2 can promote esophageal squamous cell carcinoma as it is commonly amplified in esophageal squamous cell carcinomas (71) and capable of driving cancer in overexpression mouse models (38, 120). Here, SOX2 is linked to esophageal squamous cell carcinoma.